Open to all Johns Hopkins University Junior Faculty Members   The Clinical Research Scholars Program (KL2) is accepting applications for the 2021 KL2 Mentored Career Development Awards. KL2 supports the career development of junior faculty members dedicated toward a career in clinical investigation. This is a three year program and support is provided for two years by KL2 and one year by the nominating division/department.   The application deadline is Tuesday, December 1, 2020 by 11:59 pm.   Awards consist of: – Up to $110,000 in annual salary support (plus fringe) for 2 years. – Up to $30,000 to support […]

We are now accepting applications for our  TL1 Postdoctoral Biodesign Training Program. This one year program provides salary and tuition support, with an option of earning a Master’s Degree in Biodesign and Innovation in the Whiting School of Engineering. Biodesign develops trainee skills and awareness in a wide range of topics, such as design principles, technical functionality, evaluation, regulation, reimbursement, and organizational leadership.   Postdoctoral fellows, residents, fellows, as well as PhD post docs are eligible to apply. Preferred candidates are those who can commit 1-year full-time to the program (a part-time option is also available) and are: Interested in a […]

Boost and Popel are clinical research grants that award Clinical Research Unit (CRU) services, including research space, overnight beds, phlebotomy, specialized research nursing, and CRU-based imaging (i.e. DXA, CV core) to investigators, based on scientific merit. Grants are for one year with possible renewal based on study progress and achieving pre-determined milestones.

February 8 – 12, 2021 Applications due December 14, 2020 http://www.neurotherapeuticscourse.org/submit-an-application.html   This NIH-sponsored 5-day course focuses on the drug discovery and development of novel neurotherapeutics. It’s a mix of didactic lectures, workshops, round robins, and one-on-one academic/pharma mentorship. It has been very popular, with excellent reviews from past participants, and taught by a mix of Pharma industry and academic drug discovery professionals. Please pass to along to any student/post doc/fellow/faculty that might be interested in attending. For more information and the application, visit:  http://www.neurotherapeuticscourse.org/. Deadline for the application is DECEMBER 14, 2020. If you have any questions, please feel free to contact […]

At Johns Hopkins, OpenSpecimen is currently used in multiple departments, including several Precision Medicine Centers of Excellence (PMCOE).

Johns Hopkins and Kaiser Permanente Research Collaboration fosters and promotes synergistic research between Kaiser Permanente and Johns Hopkins Medicine. Application Deadline:  5:00 pm, Tuesday, January 5, 2021.   The Johns Hopkins and Kaiser Permanente Research Collaboration Committee (RCC) is actively requesting proposals for collaborative research opportunities. As part of the Institute for Clinical and Translation Research pilot program, the KP/JHM research initiative seeks to support collaborative epidemiologic, health services and related clinical research to be conducted jointly by Kaiser Permanente and Johns Hopkins researchers. Research proposals should highlight the effective synergy of the Kaiser Permanente/Johns Hopkins collaboration in tackling the complex and […]

  [See Clarification of Eligibility Criteria Issued on 22NOV20]   The Accelerated Translational Incubator Pilot (ATIP) Program is milestone-driven and provides up to $100,000 over twelve months in targeted funding for faculty conducting translational research projects.   The ICTR is now requesting applications with a deadline for submission by 5:00 pm Monday, December 7, 2020. Johns Hopkins University faculty members interested in funding for a new or ongoing translational project may be eligible to apply*. Proposals submitted for consideration must satisfy the following requirements: Focused on the translation of laboratory and/or clinical research into new interventions that can be brought to patients within 3 to 5 years […]

“Prediction model” can help hospitals forecast which patients’ conditions are likely to worsen. This article discusses the JH-CROWN registry.   A combination of demographic and clinical data gathered from seven weeks of COVID-19 patient care helped Johns Hopkins researchers build a “prediction model” they say can help hospitals care for COVID-19 patients — and make important decisions about planning and resource allocations. Brian Garibaldi, associate professor of medicine at the Johns Hopkins University School of Medicine and director of the Johns Hopkins biocontainment unit, led a team that published an article in the September 2020 issue of Annals of Internal Medicine that […]

November 3, 2020   We are very pleased to announce that Kelly Dooley, MD, MPH, PhD and David Hager, MD, PhD will join the ICTR COVID-19 Clinical Research Center as Deputy Directors.   Dr. Dooley is an Associate Professor of Medicine & Pharmacology with appointments in Clinical Pharmacology and Infectious Diseases. Her research focuses on tuberculosis therapeutics with an emphasis on clinical trials of TB drugs and HIV/TB co-treatment. She is on the scientific committees of the Tuberculosis Trials Consortium, AIDS Clinical Trials Group, and IMPAACT networks and is the Clinical Trials Site leader for JHU’s ACTG HIV trials unit. […]

We are now accepting applications for our  TL1 Postdoctoral Biodesign Training Program. This one year program provides salary and tuition support, with an option of earning a Master’s Degree in Biodesign and Innovation in the Whiting School of Engineering. Biodesign develops trainee skills and awareness in a wide range of topics, such as design principles, technical functionality, evaluation, regulation, reimbursement, and organizational leadership.   Postdoctoral fellows, residents, fellows, as well as PhD post docs are eligible to apply. Preferred candidates are those who can commit 1-year full-time to the program (a part-time option is also available) and are: Interested in a […]

The goal of the Henrietta Lacks Memorial Lecture series is to describe the reach and complexity, both biomedically and ethically, of the story of Henrietta Lacks and HeLa cells as well as to provide some insight into the past, present, and future of the conduct of clinical research. By honoring Mrs. Lacks and the positive global impact of HeLa cells through this lecture series, the ICTR hopes to acknowledge, thank and honor everyone who participates in the clinical research process.